Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer

World Journal of Gastroenterology

Volumn 11, Issue 11, 2005, Pages 1668-1672

  Zheng, Hai Tao ^a   Peng, Zhi Hai ^a   Zhou, Chong Zhi ^a   Li, Da Peng ^a   Wang, Zhao Wen ^a   Qiu, Guo Qiang ^a   He, Lin ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Chromosome 22; Gene mapping; Heterozygosity; Sporadic colorectal cancer

Indexed keywords

DNA; FLUORESCENT DYE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER TISSUE; CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME MAP; CLINICAL FEATURE; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER PROGRAM; CONTROLLED STUDY; DNA DETERMINATION; ELECTROPHORESIS; FEMALE; GENE IDENTIFICATION; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

EID: 17144379404     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i11.1668     Document Type: Article

References (24)

1. Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer 1999; 35 335-351
2. Fearon ER, Volgelstein B. A genetic model for colorectal tumerigenesis. Cell 1990; 61: 759-767
3. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science 1989; 244: 207-211
4. Peng Z, Zhang F, Zhou C, Ling Y, Bai S, Liu W, Qiu G, He L, Wang L, Wei D, Lin E, Xie K. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer. Int J Gastrointest Cancer 2003; 34: 39-48
5. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. A comprehensive genetic map of the human genome based on 5 264 microsatellites. Nature 1996; 380: 152-154
6. Miyakawa A, Wang XL, Nakanishi H, Imai FL, Shiiba M, Miya T, Imai Y, Tanzawa H. Allelic loss on chromosome 22 in oral cancer: Possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol 1998; 13: 705-709
7. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994; 54 45-47
8. Englefield P, Foulkes WD, Campbell IG. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and not accompanied by mutations in NF2 at 22q12. Br J Cancer 1994; 70 905-907
9. Iida A, Kurose K, Isobe R, Akiyama F, Sakamoto G, Yoshimoto M, Kasumi F, Nakamura Y, Emi M. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer 1998; 21: 108-112
10. Chung DC, Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT, Arnold A. Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res 1998; 58: 3706-3711
11. Fukasawa T, Chong JM, Sakurai S, Koshiishi N, Ikeno R, Tanaka A, Matsumoto Y, Hayashi Y, Koike M, Fukayama M. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor. Jpn J Cancer Res 2000; 91: 1241-1249
12. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 1993; 17: 794-799
13. Zhou CZ, Peng ZH, Zhang F, Qiu GQ, He L. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J Gastroenterol 2002; 8: 668-673
14. Castells A, Gusella JF, Ramesh V, Rustgi AK. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res 2000; 60: 2836-2839
15. Castells A, Ino Y, Louis DN, Ramesh V, Gusella JF, Rustgi AK. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology 1999; 117: 831-837
16. Huang B, Starostik P, Kuhl J, Tonn JC, Roggendorf W. Loss of heterozygosity on chromosome 22 in human ependymomas. Acta Neuropathol 2002; 103: 415-420
17. Bufill JA. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990; 113: 779-788
18. Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 1997; 15: 302-311
19. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 2001; 13 63-69
20. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001; 195 171-178
21. Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, House A, Iacopetta B. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res 1997; 3 1405-1411
22. Lanza G Jr, Maestri I, Dubini A, Gafa R, Santini A, Ferretti S, Cavazzini L. p53 expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern and short-term survival. Am J Clin Pathol 1996; 105: 604-612
23. Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP. The DNA sequence of chromosome 22. Nature 1999; 402 489-495
24. Castellvi-Bel S, Castells A, Johnstone CN, Pinol V, Pellise M, Elizalde JI, Romo N, Rustgi AK, Pique JM. Evaluation of PARVG located on 22q13 as a candidate tumor suppressor gene for colorectal and breast cancer. Cancer Genetics Cytogenetics 2003; 144: 80-82